Future trends in viral vector process & product development
Cell & Gene Therapy Insights 2022; 8(3), 447–450
DOI: 10.18609/cgti.2022.067
Published: 28 April 2022
Viewpoint
“As the program portfolios of companies mature, there is a need for appropriate scale-up or scale-out of viral vector manufacturing strategies.”